Home › Trials › Prostate & bladder

Bladder cancer

To study the effect of two commonly used chemotherapy regimens (GC and ddCMV) given with immunotherapy for localised bladder cancer(MIBC)

Who can joinAdults

Age18+ years

Kind of studyPhase 3: compared with usual treatment

What it testsA medicine and surgery or a procedure

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Contact hospital

The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.

Christian medical college, VelloreVelloreDirections ↗

Registry summary (technical)

A phase II open label randomized trial of neoadjuvant chemoimmunotherapy with either dose dense Cisplatin, Methotrexate, Vinblastine (ddCMV) OR Gemcitabine and Cisplatin (GC) for muscle invasive bladder cancer (MIBC) - NEOBLITZ- NEOadjuvant therapy in BLadder cancer with Immuno-chemotherapy in muscle invasive TumorZ

Sponsor: Christian medical college, Vellore
CTRI/2025/11/097365 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 17 Nov 2025 · read by us 5 Nov 2026

Need help reaching the trial team? Write to us.

Tell us the city, the type of cancer and the trial number if you have one. We reply in simple words within 3 working days.

ट्रायल टीम से जुड़ने में मदद चाहिए? हमें ईमेल करें।

ట్రయల్ టీమ్‌ను సంప్రదించడానికి సహాయం కావాలా? మాకు ఈమెయిల్ చేయండి.

சோதனைக் குழுவை தொடர்பு கொள்ள உதவி வேண்டுமா? எங்களுக்கு மின்னஞ்சல் செய்யுங்கள்.